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A B S T R A C T
Objectives: The 6-exon-spanning ‘canonical’ Interleukin-7 (IL-7c) is a non-redundant cytokine in human
T-cell homeostasis that undergoes extensive alternative pre-mRNA splicing. The IL-7 gene variant
lacking, exon 5 (IL-7d5), exhibits agonistic effects as compared to IL-7c. We studied in this report for the
ﬁrst time the protein expression of IL-7d5 variant in tissues and its role in monocyte activation.
Methods: We visualized the expression of IL-7d5 protein by immunohistochemistry in both healthy and
malignant (human) tissues and investigated the impact of IL-7d5 stimulation on CD14+ monocytes using
gene expression analysis and ﬂow cytometry.
Results: IL-7d5 is largely expressed by human epithelial cells, yet also by stromal cells in malignant
lesions. Gene expression analysis in CD14+ monocytes, induced by the 6-exon spanning IL-7 or IL-
7d5 showed similar changes resulting in a pro-inﬂammatory phenotype and increased expression of
genes involved in lipid metabolism. IL7d5 was superior in inducing upregulation of the oxidised low
density lipoprotein receptor (OLR), measured by ﬂow cytometry, in CD14+ cells.
Conclusion: IL-7d5, produced from non-transformed and transformed cells, may contribute to chronic
inﬂammatory responses and development of ‘foamy’ cells by increased OLR1 expression that mediates
increased oxLDL uptake.
© 2017 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Interleukin-7 (IL-7) is a well-studied, non-redundant cytokine in
T-cell biology.1–4 The role of IL-7 in shaping immune compartments
is increasingly being understood, particularly in the case of innate
lymphoid cells and during formation of the secondary lymphoid
structures.5–7 As observed in most eukaryote species, the human IL-
7 gene is known to undergo alternative splicing at the pre-mRNA* Corresponding author at: Division of Therapeutic Immunology (TIM), Depart-
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six ‘in frame’ mRNA species generated by exon skipping of exons 3,
4 and 5, or their respective combinations. IL-7d5 is one of the
alternatively spliced IL-7 variants which lacks the ﬁfth exon in the
canonical IL-7 m-RNA (IL-7c).8,9 IL-7d5 is the only IL-7 gene variant
that interacts with the IL-7 receptor (IL-7R, CD127) and has been
shown to act as an ‘IL-7 super-agonist’ deﬁned by signalling events.8
IL-7c protein expression in situ, i.e in organs or tissues, is less
understood in humans. Most data concerning IL-7 protein have
been obtained by the examination of human thymic cells, bone
marrow stromal cells10 intestinal epithelial cells,11 skin or liver
tissue.12 A far better understanding of IL-7 protein expression can
be obtained in murine models,13 but these studies cannot take into
account the extent and diversity of human IL-7 variants as the pre
m-RNA splicing events are different for humans and mice IL-7: IL-
7 does not undergo alternative splicing in mice similarly as theious Diseases. This is an open access article under the CC BY-NC-ND license (http://
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7 variants can impact on neural cell differentiation and tumour cell
migration,14,15 the biology of IL-7 variants and the cells producing
IL-7 variants have not been studied in detail up to now.
Previous studies addressed the question whether IL-7d5
variants are present at the transcript level.8,9 In this study, we
studied IL-7d5 protein expression in healthy and diseased human
tissue by immunohistochemistry and explored the transcriptomic
changes induced by IL-7c or the IL-7d5 in CD14+ monocytes.
Material and methods
Reagents and samples.
IL-7c and IL-7d5 were produced in a CHO cell expression system
and provided by Cytheris Inc. (Cytheris Inc., Paris, France). The
isoform speciﬁc reagent, a polyclonal antibody (monospeciﬁc)
directed against the IL-7d5 protein, recognizes a unique junction
peptide on the IL-7d5 surface. The antibody was produced
inrabbits (Ethical approval no dnr. A 52-11, animal ethics committee
Stockholm), followed by afﬁnity-puriﬁcation using the immunizing
peptide. The speciﬁcity has been conﬁrmed to detect exclusively the
IL-7d5 protein (Rane et al., submitted for publication). Human buffy
coat samples from healthy blood donors were obtained from the
Karolinska Blood Component Unit (approved by local ethical
committee Dnr.2010- 760-31) and PBMC separation was carried
out by a ﬁcoll gradient to obtain peripheral blood mononuclear cells
(PBMC) for gene expression and ﬂow cytometry analysis.
IL-7d5 protein detection by Immunohistochemistry was
performed using commercially available Human FDA/CE Standard
Normal Frozen Tissue Arrays, Human Cancer/Normal Frozen Tissue
Arrays and Frozen Single Tissue Section Slides from Human
Arteriosclerosis Aorta and Matched Non-arteriosclerosis Aorta
purchased from Biocat Inc. (Heidelberg, Germany).
Immunohistochemistry
Frozen tissue sections were tested for IL-7d5 production by the
ABC-method using diaminobenzidine substrate (Vector laborato-
ries, Burlingame; CA, USA) and hematoxylene for nuclear counter
staining. Brieﬂy, the fresh frozen tissue array slides are thawed in a
humidity chamber and tissue sections were permeabilized using
saponin (Sigma Aldrich AB, Stockholm, Sweden) for 10 minutes
followed by incubation with the rabbit anti–human IL-
7d5 antibody or a mouse anti-human IL-7 monoclonal antibody
(clone B-N18, Diaclone inc, Besancon Cedex, France) overnight at
4 C. Positive immunostaining was detected using a biotinylated
secondary swine anti-rabbit F(ab’) antibody and goat anti-mouse
IgG respectively and developed by addition of a diaminobenzidine
substrate (DAB, Vector laboratories, Burlingame, USA). Haematox-
ylin stain was used to counterstain the nuclei. Stained images were
analyzed on a DMR-X microscope to determine the percent
positively stained area in the total cell area using the computerized
image analysis system Quantimet Q5501W (Lecia Microsystems.
Wetzlar, Germany, Qwin 550 program).
IL-7d5 production in CD14+ monocytes
Among circulating human lymphocyte populations, monocytes
themselves are a source of IL-7 protein.8 To investigate the relative
abundance of IL-7d5 transcript in CD14+ monocytes in comparison
with whole blood and PBMCs, heparinized blood was obtained
from healthy donors and immediately processed to obtain the
PBMC fraction by a ﬁcoll gradient. The CD14+ cells were separated
from the PBMC using CD14+ magnetic beads and isolated by MACS
LS columns (Miltenyl biotech Inc. Lund, Sweden) according tosupplier’s instructions. Total RNA was extracted from whole blood,
PBMCs and sorted CD14+ monocyte subsets using the Qiagen
RNeasy plus RNA extraction kit (Qiagen Inc. Hilden, Germany). 1 ug
of total RNA from each extract was converted to cDNA using
OligodT cDNA synthesis protocol from RevertAid ﬁrst strand cDNA
synthesis kit (Thermo scientiﬁc, Hudson, NH, USA). The measure-
ment of the IL-7 isoform relative distribution was performed by
amplifying the complete IL-7 gene sequence by PCR using primers
IL-7 forward: 50 GCAGACCATGTTCCATGTTTC(21), IL-7 reverse: 50
CAGTGTTCTTTAGTGCCCATCA (22) and analyzed using the Agilent
2100 DNA 1000 capillary electrophoresis kit (Agilent Inc., CA, USA)
as described previously.9
Microarray gene expression analysis
CD14+ monocytes were separated by magnetic labeling from a
freshly harvested human buffy coat obtained from healthy donors.
The purity of separation was analyzed by ﬂow cytometry analysis
and conﬁrmed to be at least 97%. 2 million CD14+ cells were
stimulated with either 100 ng/ml IL-7c CHO or 100 ng/ml IL-
7d5 CHO to ensure optimal stimulation, along with unstimulated
control (CD14 + ) cells (1 million cells/ml serum free AIMV
medium; Gibco, Life Technologies, Gaithersburg, MD, USA) to
avoid unspeciﬁc stimulation caused by fetal bovine serum
components.Cells and cell culture supernatants were harvested
after 72 hours of stimulation and total RNA was extracted using the
Qiagen RNeasy plus RNA extraction kit (Qiagen Inc. Hilden,
Germany). Gene expression analysis was performed at Bioinformat-
icsand Expression Analysis (BEA)corefacilityat Karolinska Institutet
using affymetrix platform and the affymetrix human gene ST1.1 kit.
Results werenormalizedby RMAexpresssoftware(http://stat-www.
berkeley.edu/users/bolstad/RMAExpress/RMAExpress.html). Nor-
malized data were analyzed by Signiﬁcance of Microarray (SAM)
test using MeV software (Saeed AI, 2013) to identify gene expression
changes in IL-7c and IL-7d5–stimulated cells against unstimulated
controls. The genes which were differentially regulated among the
treatment were analyzed and clustered according to biological
processes represented by them using PANTHER database.16
Measurement of chemokines and cytokines
Cell culture supernatants after 72 hours of culture in IL-7c, IL-
7d5 or medium (unstimulated control group) were harvested and
analyzed for cytokines and chemokines. The measurement was
performed using the Luminex 26 plex panel (Luminex inc. Austin,
TX) on a Luminex 100 instrument according to supplier’s
instruction. Values from unstimulated (CD14+) controls were
subtracted to obtain net values for IL-7 and IL-7d5 mediated
cytokine and chemokine production from CD14+ monocytes.
OLR1 expression on CD14+ monocytes
The effect of IL-7 and IL-7d5 on up regulating OLR1 gene
expression on CD14+ monocytes at the protein level, was
investigated using ﬂow cytometry. Peripheral blood mononuclear
cells from healthy individuals were stimulated by either 100 ng/ml
IL-7c or 100 ng/ml IL-7d5 for 72 hours in serum free AIMV medium.
The cells were collected at the end of the stimulation and stained
for expression of OLR1 protein using the PerCP anti-human
OLR1 antibody (clone 472413, R&D Biosystems, UK) along with anti
CD14 APC-H7(clone MwP9, BD Biosciences) and CD3-ECD (clone
UCHT1, Beckman Coulter Inc. USA). The ﬂow cytometry analysis
was performed on a FACSAria instrument (BD Biosciences,
Stockholm, Sweden) and results were analyzed using FlowJo
analysis software. The analysis was performed by deﬁning the
parental lymph population based on forward and side scatter,
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gate. CD14+ cells were obtained from the CD3 negative cell
population and OLR1 expression was identiﬁed on CD14+ and
CD14  cells. The data were obtained as percentage of
OLR1 positive cells in the CD14+ cell subset and visualized for
each donor according to treatment group. Statistical analysis was
performed using one way ANOVA test to investigate the statistical
signiﬁcance of the difference between the treatment groups. The
test results are provided for 6 individual donors.
Results
IL-7d5 protein is expressed in healthy and transformed human tissue
The mono-speciﬁc anti-human IL-/d5 antibody was used
to identify IL-7d5 protein production in healthy human tissueFigure 1. The monospeciﬁc antibody against IL-7d5 enabled identiﬁcation of the IL-7 d
representative tissue sections from human healthy tissues stained for IL-7 d5 using the r
recognizing all IL-7 transcript variants was used as a positive control. The IL-7d5 staining
tissues. In general, the IL-7d5 staining is largely associated to epithelial cells in skin and th
from spinal cord and cerebral cortex.(Figure 1). We examined the presence of IL-7d5 in tissue sections
from 10 different anatomical sites representing skin, mucous
membranes, glandular organs, reproductive organs and the
nervous system (Table 1); as well as in human atherosclerosis
aorta and matched, normal aorta (supplementary Figure S3). IL-
7d5 reactive cells are present in all tissues sections mainly
associated with epithelial cells.
A functional IL-7R signalling complex has been described to be
expressed on tumor cells17 and IL-7c, as well as IL-7d5 have been
proposed to promote tumor cell proliferation.15,18,19 This prompted
us to explore IL-7d5, protein production in tumor tissue as
compared to the corresponding healthy tissue (Figure 2). IL-
7d5 protein expression was found to be stronger in tumor lesions
as compared to healthy tissue. IL-7d5–positive cells were not only
conﬁned to tumor cells, yet also to cells within the tumor stroma,
including monocytes (Table 2).5 protein expression in human tissues. The immunohistochemistry staining shows
abbit anti-hIL-7d5 antibody. A control monoclonal antibody (‘IL-7mono’) capable of
 reaction is positive in all tissue sections but with distinct patterns among different
e gastrointestinal tract, it can also be observed scattered among cells in the sections
Table 1
Compilation of IL-7d5 staining characteristics in tissue sections.
No. Tissue expression IL-7d5 staining pattern
1 Breast ++ associated mostly with glandular structures
2 Prostate ++ associated with glandular epithelial cells
3 Ovary ++ epithelial cells
4 Testis + associated with vascular epithelial layer
5 Spinal cord + present in a few scattered cells
6 Skin +++ the subcutaneous epithelial cells are strongly positive; scattered expression in connective tissue
7 Oesophagus + few positive cells
8 Colon +++ strong positive staining associated with epithelial cells
9 Cervix + Imbibition of cells with IL-7d5 reactive material
10 Cerebral cortex + present in a few cells scattered in CNS tissue
Summary of IL-7d5 staining (Figure 1), graded from weak (+) to strong (+++) IL-7d5 reactive material based on number of positive cells in respective section.
Figure 2. The IL-7d5 protein was visualized in tumor tissue sections (T) along with corresponding normal tissues (N) using immunohistochemistry on tissue sections of skin,
pancreas, brain, breast, prostate, small intestine, skeletal muscle, colon and uterus. IL-7d5 protein distribution is associated with epithelial cells in healthy tissue.
Sections from corresponding tumor tissues stained positive for cells distributed in tumor lesions.
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Next, we investigated the presence and relative abundance of
IL-7d5 mRNA by calculating the percent abundance of IL-
7d5 transcript among all IL-7 alternatively spliced transcriptsampliﬁed in an end-point PCR (Supplementary Figure 1) in CD14+
monocytes. We observed the presence of four different alterna-
tively spliced IL-7 transcripts in monocytes (IL-7c, IL-7d5, IL-7d4,
IL-7d4,5), whereas six IL-7 alternatively spliced variants (IL-7c, IL-
7d5, IL-7d4, IL-7d4,5, IL-7d3,4, and IL-7d3,4,5) were measurable in
Table 2
Compilation of IL-7d5 staining in healthy tissue and malignant lesions.
No Tissue Healthy Tumor
A Skin subcutaneous epithelial cells diffused expression throughout the tumor mass
B Pancreas positive staining in few cells scattered in pancreatic tissue sporadic and does not seem to be associated with tumor cells
C Brain appear to be scattered in the brain tissue mostly associated with tumor mass
D Breast epithelial cells of the mammary gland associated with tumor cells
E Prostate present in epithelial layer and few cells positive in surrounding
tissue
glandular structure is stained positive but sporadic expression in surrounding
tissue
F Small
Intestine
low/sporadic expression diffused in the section low but consistent expression diffused in the section
I Skeletal
muscle
muscle ﬁber as well as vasculature is positively stained seems absent
J Colon positive staining reaction for IL-7d5 protein in epithelial cells mostly associated with epithelial tumor cells
K Uterus associated with smooth muscle cells low level of expression throughout the tumor
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7d5 transcript constituted almost 15% of the total IL-7 transcript
in CD14+ monocytes, yet represented less than 3% in whole blood
or PBMCs suggesting that CD14+ monocytes may contribute IL-
7d5 production in peripheral blood cells.
Effect of IL-7d5 on gene expression in CD14+ monocytes
As monocytes also express IL-7R on the cell surface,20,21 we
investigated the effect of IL-7 or IL-7d5 on monocytes by gene
expression proﬁling. The statistical analysis by signiﬁcance of
microarray test (SAM) identiﬁed 81 protein coding transcripts
which were signiﬁcantly upregulated at 10% false discovery rate
(FDR) in IL-7c versus unstimulated cells and 19 upregulated genes
for IL-7d5-stimulated versus unstimulated CD14+ cells. Interest-
ingly, we did not identify signiﬁcant downregulation of coding
genes at 10% FDR with either IL-7c or IL-7d5 treatment.Figure 3. Heat map of differentially regulated genes in human CD14+ cell subset upon IL
from 0 (blue) to 7.53 (red) in a color gradient manner. The CD14+ cells show differentia
shows genes that are differentially regulated by either IL-7c or IL-7d5. The largest gene clu
including lipid metabolism.Differentially expressed genes were clustered using the
pathway analysis and ontology tool to visualize physiological
processes (Figure 3). Both IL-7c and IL-7d5 treatment resulted in
upregulation of genes involved in metabolic processes, cell
communication and cellular response elements to external stimuli.
The genes clusters with signiﬁcant enrichment based on functional
grouping at less than 5% FDR formed 7 clusters (supplementary
table S1) with genes involved in G1/S phase transition, response to
stress and upregulation of immune response. The surface receptor
transcripts among the upregulated genes indicated a pro-
inﬂammatory phenotype, particularly through the upregulation
of the Oxidised Low density Lipoprotein Receptor-1 (OLR-1) gene
(Figure 3).
Cytokine and chemokine production in response to IL-
7d5 stimulation was assessed by a 26 plex Luminex based
multiplex cytokine panel (Supplementary Figure 2). We did not
observe statistically relevant differences in cytokine levels-7c and IL-7d5 stimulation (A). The picture represents log10 gene expression values
lly regulated genes upon IL-7 and IL-7d5 treatment. The gene ontology analysis (B)
ster in IL-7c or IL-7d5 treated CD14+ cells are genes involved in metabolic pathways
34 L. Rane et al. / International Journal of Infectious Diseases 59 (2017) 29–36between the IL-7 and IL-7d5 treatment groups. Both IL-7 and IL-
7d5 induced increased GMCSF, IFNg, IL-10, and IL-1a in superna-
tant from (unseparated) PBMCs compared with unstimulated
control cells; but the increased cytokine production was not
present in supernatants from highly puriﬁed (>97% purity) CD14+
cells. Similarly, chemokines from IL-7c or IL-7d5 stimulated PBMC
cultures were upregulated deﬁned by increased etoxin, MCP-1,
MIP-1a, MIP-1b and IP-10. Analysis of supernatants from CD14+
cells showed increased (MIP1a) production upon IL-7 and IL-
7d5 stimulation.
IL-7d5 increases OLR1 expression in CD14+ cells
In order to conﬁrm the observation of increased OLR1 gene
expression upon Il-7d5 stimulation, we tested OLR1 protein
expression on IL-7 or IL-7d5-stimulated CD14+ cells. PBMCs
obtained from (n = 6) healthy subjects were cultured in IL-7c or IL-
d5 for 72 hours and exhibited an increase in CD14+ cells expressing
the OLR1 protein (Figure 4). The frequency of CD14+ OLR1+ cells in
unstimulated controls was 0,32% (STDV 0.104) of the total CD14+
population which increased to 3.16% (STDV 3.15) with IL-7c
stimulation and 4.34% (STDV 2,87) with IL-7d5. The change in
frequency of CD14+ cells expressing OLR1 (p = 0.035) was
signiﬁcant among the treatment groups with the one way ANOVA
test. Statistical analysis between the groups using paired T- test
revealed that the frequency of CD14+ cells expressing OLR1 is
signiﬁcantly different between unstimulated cells and the IL-
7d5 treatment group (p = 0.02). The same was found to be true for
the comparison of IL-7c vs IL-7d5 (p = 0.05).Figure 4. Expression of the oxidized low density lipoprotein receptor was investigated 
using side and forward scatter within the parental lymph gate. CD3+ cells were identiﬁed
CD14+ cells was investigated for each donor and the frequency of OLR1 expressing CD14
shape and color denotes a donor, the X axis represents the frequency of CD14+ OLR
(unstimulated), IL-7c and IL-7d5). The frequency of CD14+ OLR1+ cells was obtained foDiscussion
IL-7 pre-mRNA alternative splicing gives rise to 6 different
variant proteins.9 We have previously mapped the IL-7 alternative
splicing at the mRNA level in tissues of human origin and noted
that the alternative splicing pattern of the IL-7 gene is unique
based on the tissue origin.8 IL-7d5, in addition to the 6-
exonspanning IL-7, appears to be biologically relevant since it
has been shown to mediate STAT5 phosphorylation upon T-cell
stimulation and to drive maturation of human thymocytes.8 IL-
7d5 m-RNA was predominantly found in liver, salivary gland,
thyroid, stomach, peripheral blood mononuclear cells, in testis as
well as in granuloma lesions from individuals with latent TB.8 More
recently, we investigated the role of IL-7d5 in T-cell activation and
were able to i) produce a mono-speciﬁc IL-7d5 reactive antibody
and ii) showed that IL-7d5 is able to induce stronger BCL-
2 production in human T-cells as compared to the 6-exon full
length IL-7 (Rane and coworkers, submitted). In this report, we
investigated the production of IL-7d5 protein in healthy and
transformed human tissue and tested its impact of human CD14+
monocytes.
Most of the data available to date stem from IL-7 gene
expression analysis using a reporter murine model13,22,23 and there
is only limited data available on IL-7 protein staining in human
tissue.24. The inherent differences in pre-mRNA processing of the
IL-7 gene in humans, as compared to mice, makes the IL-7 gene
expression information from murine models inconclusive if
(human) IL-7 gene alternative splicing is to be measured. The
canonical (corresponding to full length protein) IL-7 gene in miceby ﬂow cytometry. The scatterplot shows the gating strategy, cells were visualized
 and the CD3- cell population was used to identify CD14+ cells. OLR1 expression on
+ cells was used to compare the effect of IL-7d5 treatment. In the scatter plot, each
1+ cells in the CD14+ cell subsets; the stimulus is indicated on the Y axis (UNS
r each group and compared using one way ANOVA.
L. Rane et al. / International Journal of Infectious Diseases 59 (2017) 29–36 35consists of 5 exons where its human counterpart is comprised of
6 exons and produces nine alternatively spliced mRNA species.
Circulating Interleukin-7 protein levels are quite low,10
suggesting IL-7 in situ production and subsequent consumption
of IL-7 by IL-7R+ cells. This led to the suggestion that IL-7R+ tumor
cells may provide a ‘sink’ for biologically available IL-7 limiting the
availability of IL-7 to T-cells. Studies addressing IL-7 protein
expression, using reporter mice, showed IL-7 gene expression in
mesenchymal and epithelial cells in lymphoid organs, in the
epithelial cells of the intestine, liver skin and lung tissue.22,23 This
corresponds to the limited data available for human tissues, yet
these studies can only address the full length IL-7 transcripts in
mice (due to the lack of alternative splicing). Protein expression
analysis in human tissues has not been able to address the
presence of speciﬁc IL-7 isoforms due to the lack of speciﬁc
reagents; this has been remedied here in this report.
The monoclonal antibody used as a control reagent has been
shown to recognize several IL-7 isoforms, including the full length,
6 exon IL-7c, as well as IL-7d5. Thus, we have at this point not a
reagent available that would only stain for IL-7c. Using the speciﬁc
reagent that reacts exclusively with Il-7d5, we were able to show
IL-7d5 protein expression in most healthy and transformed tissues.
Similar to IL-7c (as deﬁned by mRNA length analysis deﬁning
isoforms), the IL-7d5 protein production was associated with cells
of epithelial origin in healthy tissue, but appeared to be more
diffuse in tumors, which could be due to either increased IL-
7d5 protein production and/or IL-7 producing stromal cells in
malignant lesions, including ﬁbroblasts. Not only ﬁbroblasts, but
also tissue resident monocytes or monocyte-derived cells are
known to express IL-7 and could therefore be sources for local IL-7
production.25–27
IL-7d5 production has been shown to be associated with CD68+
cells in patients with TB, suggesting that M. tuberculosis-infected
monocytes or monocyte-directed cells could serve as a source for
IL-7d5 production in situ (Rane et al., submitted). This is of
particular interest since the receptor for IL-7 (CD127) is known to
be expressed by circulating monocytes as well as by dendritic cells.
IL-7 stimulation of monocytes has been shown to increase
recruitment to endothelial areas in an atherosclerosis murine
model.28
IL-7c stimulation of monocytes leads to an pro-inﬂammatory
phenotype.20 Our investigations (supplementary Figure S2)
substantiate this ﬁnding with a strong production of MIP1a in
both IL-7c or IL-7d5 stimulated CD14+ cells. The transcriptomic
analysis showed that IL-7c and IL-7d5 induce very similar changes
(Figure 3) in CD14+ monocytes with a trend of increased gene
transcripts involved in lipid metabolism particularly for IL-7d5,
mainly through upregulation of the oxidized low density lipopro-
tein receptor 1 (OLR1) molecule, a ﬁnding that was corroborated
via ﬂow cytometry (Figure 4). OLR1, represents a lectin-like
scavenger receptor that is conserved in mammals.29
OLR1 recognizes several ligands, e.g. oxidized-LDL (ox-LDL),
gram-positive and gram-negative bacteria as well as apoptotic
cells.30 Overexpression of OLR1 has been shown in atherosclerotic
lesions31; an interesting observation is that IL-7d5, which induces
OLR1 expression, is also strongly expressed in atherosclerotic
plaques (supplementary Figure S3). OLR-1 expression on mono-
cytes is known to mediate inﬂammatory changes in CD14+
monocytes, in part by activating NF-kB.32 Recent studies have
linked the expression of the lectin-like ox-LDL receptor 1 (OLR1) to
tumorigenesis suggesting that OLR1 may serve as an ‘oncogene’ by
NF-kB activation leading to aberrant cellular proliferation,
migration, as well as inhibition of apoptosis and activation of de
novo lipogenesis.33
The observation that IL-7d5 is strongly expressed in healthy
tissue as well as in tumor lesions may have several biologicalconsequences. First, IL-7d5, elaborated in situ, may induce BCL-
2 expression and increase survival, not only in immune cells,
yet also in cells undergoing malignant transformation. IL-7c has
also been shown to overcome tumor-induced CD27-CD28-
suppressor cells,34 the role of IL-7d5 in rescuing biologically
relevant anti-tumor responses has to be determined. Second, IL-
7d5 may contribute to OLR1 expression on tumor cells. The effects
may be diverse: Components of oxLDL have been shown to
stimulate cellular proliferation, mutagenesis in vitro35 and to
induce epithelial mesenchymal transition.36 In contrast, oxLDL
mediated effects, via OLR1, may also be able to arrest cell growth
activating p53-dependent apoptosis or initiate autophagy.37,38
Since earlier studies showed preferential expression of IL-7d5
(on the mRNA level) in patients with latent TB,8 the IL-
7d5 mediated upregulation of OLR1 may be instrumental for
anti-M.tuberculosis directed immune responses. M. tuberculosis has
been shown to drive differentiation of macrophages into foam
cells, characterized by lipid body biogenesis. These lipids provide
nutrients to M.tuberculosis, leading to an enhanced ability to
survive and replicate in host cells. This pathogen-induced
manipulation of the host machinery is responsible for the survival
of M. tuberculosis inside the macrophage and may therefore be
facilitated by IL-7d5 driven increased expression for the OLR,
leading to increased oxLDL uptake. Lipid-laden macrophages are a
prominent and consistent feature of granulomatous lesions in
animals as well as in humans infected with M. tuberculosis39,40
Lipid-laden macrophages have been shown to support the
persistence of non-replicating bacilli and demonstrated to be
defective in phagocytic and bactericidal activity.41 The diminished
antimicrobial capacity of infected macrophages may enable M.
tuberculosis to exploit this unique intracellular microenvironment
for survival and replication in vivo: loading of guinea pig lung
macrophages with OxLDL resulted in enhanced replication of
bacilli compared to macrophages loaded with non-oxidized LDL.42
M. tuberculosis mutants, with defects in cholesterol uptake, fail to
establish chronic infection in murine models.43
To conclude, we showed in this report for the ﬁrst time that IL-
7d5 is expressed in tumor lesions and that IL-7d5 leads to
OLR1 expression in human monocytes that may enable the
increased uptake of oxLDL. Increased oxLDL uptake has been
associated with increased M.tuberculosis pathogenicity and possi-
bly with malignant transformation, suggesting that IL-7d5 may
indirectly, via OLR1 upregulation, contribute to immune-patholo-
gy in infection and cancer.
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